tiprankstipranks
Advertisement
Advertisement

OMER Stock Latest News

Midday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
The FlyMidday Fly By: Argenx to buy Forte, Nvidia in talks for $250B OpenAI backstop
1d ago
F
GM
Omeros Buy Rating Reiterated as Ultomiris Setback Eases Competitive Risk; $33 Price Target Maintained
PremiumRatings
Omeros Buy Rating Reiterated as Ultomiris Setback Eases Competitive Risk; $33 Price Target Maintained
2d ago
OMER
AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright
PremiumThe Fly
AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright
2d ago
AZN
OMER
Omeros up 11% to $10.89 after AstraZeneca study failure
PremiumThe Fly
Omeros up 11% to $10.89 after AstraZeneca study failure
2d ago
AZN
OMER
Omeros Reduces Convertible Debt Through Note Repurchases
PremiumCompany Announcements
Omeros Reduces Convertible Debt Through Note Repurchases
8d ago
8K
OMER
Omeros Announces Major Convertible Notes Repurchase Plan
PremiumCompany AnnouncementsOmeros Announces Major Convertible Notes Repurchase Plan
23d ago
8K
OMER
Buy Rating Maintained on YARTEMLEA as Analyst Trims Price Target to $33 but Sees U.S. Launch Driving Upside
Premium
Ratings
Buy Rating Maintained on YARTEMLEA as Analyst Trims Price Target to $33 but Sees U.S. Launch Driving Upside
1M ago
OMER
Omeros price target lowered to $33 from $40 at H.C. Wainwright
Premium
The Fly
Omeros price target lowered to $33 from $40 at H.C. Wainwright
1M ago
OMER
Analyst Maintains Hold on Omeros, Raises Price Target to $10.72 Despite European Regulatory Setback
PremiumRatings
Analyst Maintains Hold on Omeros, Raises Price Target to $10.72 Despite European Regulatory Setback
1M ago
OMER
Omeros announces CHMP adopts negative opinion on MAA for narsoplimab
PremiumThe Fly
Omeros announces CHMP adopts negative opinion on MAA for narsoplimab
1M ago
OMER
Omeros Plans Repurchase of Convertible Senior Notes
PremiumCompany Announcements
Omeros Plans Repurchase of Convertible Senior Notes
1M ago
8K
OMER
Omeros trading resumes
PremiumThe Fly
Omeros trading resumes
2M ago
OMER
Omeros trading halted, volatility trading pause
PremiumThe FlyOmeros trading halted, volatility trading pause
2M ago
OMER
Omeros Earnings Call: YARTEMLEA Fuels a New Phase
Premium
Company Announcements
Omeros Earnings Call: YARTEMLEA Fuels a New Phase
2M ago
OMER
Omeros’ $100 Million Buyback Plan Heightens Volatility and Valuation Risk for Shareholders
Premium
Company Announcements
Omeros’ $100 Million Buyback Plan Heightens Volatility and Valuation Risk for Shareholders
2M ago
OMER
Omeros Earnings Call: YARTEMLEA Launch Drives New Phase
PremiumCompany Announcements
Omeros Earnings Call: YARTEMLEA Launch Drives New Phase
3M ago
OMER
Omeros reports Q1 adjusted EPS (24c), consensus (28c)
PremiumThe Fly
Omeros reports Q1 adjusted EPS (24c), consensus (28c)
3M ago
OMER
Omeros options imply 10.8% move in share price post-earnings
PremiumThe Fly
Omeros options imply 10.8% move in share price post-earnings
3M ago
OMER
Kyverna Therapeutics appoints Nadia Dac as chief commercial officer
PremiumThe Fly
Kyverna Therapeutics appoints Nadia Dac as chief commercial officer
3M ago
KYTX
OMER
Sagimet Biosciences appoints Grauer as Chief Medical Officer
PremiumThe FlySagimet Biosciences appoints Grauer as Chief Medical Officer
3M ago
OMER
SGMT
Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA
Premium
The Fly
Omeros says CMS assigns permanent reimbursement J-code for YARTEMLEA
3M ago
OMER
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
Premium
Company Announcements
Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
4M ago
OMER

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >